Page 35 - Read Online

Page 4 of 8 Kayiran et al. Plast Aesthet Res 2018;5:9 I http://dx.doi.org/10.20517/2347-9264.2017.86

A B

C D

Figure 2. (A, B) A 44-year-old male patient with Norwood type III patient. (A) Preoperative appearance; (B) postoperative 1-year
appearance. (C, D) A 51-year-old with Norwood type IV patient. (C) Preoperative appearance; (D) postoperative 1-year appearance

A B C

D E F

Figure 3. (A-C) A 32-year-old male patient with Norwood type III patient. (A) Preoperative appearance; (B) immediate appearance of the
patient after transplantation; (C) postoperative 1-year appearance. (D-F) A 38-year-old with Norwood type V patient. (D) Preoperative
appearance; (E) immediate appearance of the patient after transplantation; (F) postoperative 1-year appearance

[12]
growth . Mesotherapy and platelet-rich plasma can be utilized in patients needing additional therapies in the
enhancement of hair growth. Mesotherapy consists of superficial injections of pharmaceuticals and vitamin
compounds to the follicles. Platelet-rich plasma (PRP) is used in almost every section of the medicine and
includes several platelet-derived factors . It is proven that PRP injections enhance hair growth in transplanted
[13]
follicles [14-16] . Nevertheless, more studies are needed to evaluate PRP as a hair loss therapy.

Since the concept of “donor dominance” in male pattern hair loss was first published in 1959, it is still not
clear why the occipital hair is spared . The most accepted reason seems that occipital scalp is not androgen
[2]
dependent . Whatever the reason is, it is the feature that occipital hairs have permanent serves for hair
[2]
transplantation in both female and male pattern hair loss .
[2]